Try our Advanced Search for more refined results
September 18, 2013
Endo Pharmaceuticals Inc. v. Actavis, Inc.
Case Number:
13-1658
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 04, 2014
Fed. Circ. Lets Endo Opana Patent Win Stand
The Federal Circuit on Tuesday declined bids by Roxane Laboratories Inc. and Actavis Inc. to review a panel's ruling that settlements allowing the companies to sell generic versions of Endo Pharmaceuticals Inc.'s painkiller Opana ER did not include licenses for later Opana patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login